2013 - ISBTS 2013 Symposium


This page contains exclusive content for the member of the following sections: TTS, IXA, ITA. Log in to view.

Posters and Exhibition

15.10 - Renal failure(RF) associated with intestinal transplantation(Itx).Our experience

Presenter: Jorge, Calvo, , Spain
Authors: Jorge Calvo1, Alejandro Manrique1, Alvaro García-Sesma1, Enrique Morales2, Felix Cambra1, Edurne Alvaro1, Cristina Alegre1, Oscar Caso1, Manolo Abradelo1, Carmelo Loinaz1, Carlos Jimenez1, Enrique Moreno1

Renal failure(RF) associated with intestinal transplantation(Itx).Our experience

Jorge Calvo1, Alejandro Manrique1, Alvaro García-Sesma1, Enrique Morales2, Felix Cambra1, Edurne Alvaro1, Cristina Alegre1, Oscar Caso1, Manolo Abradelo1, Carmelo Loinaz1, Carlos Jimenez1, Enrique Moreno1

1Surgery, University Hospital 12 de Octubre, Madrid, Spain; 2Nephrology, University Hospital 12 de Octubre, Madrid, Spain

Introduction: It is well known that RF is a frequent complication in non-renal transplantation of solid organs. This issue is especially important in Itx.
Aim: Analyze our experience with such complication in order to find out solutions.
Patients and Methods: Between 2004 and 2013, we have performed 21 Itx in 19 adult patients. Four were multivisceral and 17 isolated Itx. Alemtuzumab is used as an induction agent  follow by tacolimus (TAC) as maintenance with or without steroids. Renal function was assessed before Itx and during the perioperative period, by means of creatinine level, GFR and creatinine clearance when possible.
Results: About 93 % of the patients under long term home parenteral nutrition (HPN);  had complications HPN related (13/14 patients) .  Main cause for transplant was irresectable desmoids tumor (37%), follow by vascular thrombosis (21%) and others. Medical complications were frequent, especially infectious diseases that were the most common complication (51% of all medical complications) from central line infection and related with the surgical mesh for temporary closure of the wound in most cases. We make universal prophylaxis against CMV and Pneumocystis carinii based upon CD4 counting. Surgical complications were frequent, but most of them (>50%) mild and related to the surgical mesh, but leading to a great number of reoperations and prolonged in hospital stay. Acute rejection (AR) is very frequent (>50%) but mild in more than half of the events, but requiring high doses of immunosuppressant drugs. RF was very frequent in our experience (68,4%; 13/19 patients) and the 14% of all medical complications. Causes leading to RF were multiple (Ileostomy, immunosuppression and medical treatment). Dialysis was needed in 3 patients in the early postoperative period. At this moment there is just 1 patient awaiting a kidney transplant.  Ileostomy closure was performed in 5/12 patients alive. In 3 patients renal function improved and in the other 2 remains stable after ileostomy closure. Of the 7 patients that remain with the functioning ileostomy 1 is awaiting a kidney transplant, 4 remain with a normal renal function and 2 have a real impaired renal function but with no need for dialysis at the moment.
Conclusions: RF is a real problem dealing with Itx patients due to multiple causes. Increases in hospital stay, morbidity and is a frequent cause for in hospital readmission in these patients. Almost all patients had an impaired renal function at the time of discharged, but this is likely to improve when the ileostomy is closed. Adding other immunosuppressant drugs in order to minimize TAC and trying to perform an ileostomy closure as soon as possible, might prevent RF.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada